Duchenne Muscular Dystrophy and Early Onset Hypertrophic Cardiomyopathy associated with Mutations in Dystrophin and Hypertrophic Cardiomyopathy-Associated Genes.
Liam AspitArwas NogaHanna KrymkoYoram EtzionRuti ParvariAviva LevitasPublished in: Journal of pediatric genetics (2020)
Duchenne muscular dystrophy (DMD) is a progressive muscular damage disorder caused by mutations in dystrophin gene. Cardiomyopathy may first be evident after 10 years of age and increases in incidence with age. We present a boy diagnosed at 18 months with a rare phenotype of DMD in association with early-onset hypertrophic cardiomyopathy (HCM). The cause of DMD is a deletion of exons 51-54 of dystrophin gene. The cause of HCM was verified by whole exome sequencing. Novel missense variations in two genes: MAP2K5 inherited from the mother and ACTN2 inherited from the father, or de novo. The combination of MAP2K5 , ACTN2 , and dystrophin mutations, could be causing the HCM in our patient. This is the second patient diagnosed, at relatively young age, with DMD and HCM, with novel variations in genes known to cause HCM. This study demonstrates the need for genetic diagnosis to elucidate the underlying pathology of HCM.
Keyphrases
- hypertrophic cardiomyopathy
- duchenne muscular dystrophy
- early onset
- genome wide
- left ventricular
- genome wide identification
- late onset
- copy number
- dna methylation
- muscular dystrophy
- genome wide analysis
- case report
- heart failure
- bioinformatics analysis
- multiple sclerosis
- oxidative stress
- risk factors
- gene expression
- resistance training
- high intensity